Twilight Co. – Trademark Portfolio
Entity Type: 03
Twilight Co. owns a portfolio of 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as M N, ETERNAL MOON, AROMA-STHESIA, and TIFFANY MOON MD. Of these, 7 are registered. The portfolio spans 5 Nice Classification classes, led by Class 14 (Jewelry) and Class 4 (Lubricants & Fuels). Headquartered in Dallas, TX.
9727 Rockbrook Dr.
Dallas, TX 75220
Showing of trademarks Trademarks
Trademark Classifications
Twilight Co.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Precious metals and their alloys; jewellery, precious stones; horological instruments
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Advertising; business management; business administration; office functions
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Twilight Co. have?
Twilight Co. has 10 U.S. trademarks filed with the USPTO. Of these, 7 registered, 3 abandoned.
What trademark classes does Twilight Co. file in?
Twilight Co. files trademarks across 5 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 4 (Lubricants & Fuels), Class 35 (Advertising & Business), Class 45 (Legal & Security Services), Class 10 (Medical Apparatus). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.
What are Twilight Co.'s most well-known trademarks?
Twilight Co.'s registered trademark portfolio includes well-known marks such as M N, ETERNAL MOON, AROMA-STHESIA, and TIFFANY MOON MD. These are among 7 currently registered trademarks in the portfolio.
What is Twilight Co.'s trademark registration success rate?
Twilight Co. has a 70% trademark registration rate, with 7 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.